GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Precision Biosensor Inc (XKRX:335810) » Definitions » Debt-to-Asset

Precision Biosensor (XKRX:335810) Debt-to-Asset : 0.34 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Precision Biosensor Debt-to-Asset?

Precision Biosensor's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩12,708 Mil. Precision Biosensor's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,954 Mil. Precision Biosensor's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩52,039 Mil. Precision Biosensor's debt to asset for the quarter that ended in Dec. 2024 was 0.34.


Precision Biosensor Debt-to-Asset Historical Data

The historical data trend for Precision Biosensor's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision Biosensor Debt-to-Asset Chart

Precision Biosensor Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.17 0.28 0.33 0.34

Precision Biosensor Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.30 0.30 0.32 0.34

Competitive Comparison of Precision Biosensor's Debt-to-Asset

For the Medical Devices subindustry, Precision Biosensor's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precision Biosensor's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Precision Biosensor's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Precision Biosensor's Debt-to-Asset falls into.


;
;

Precision Biosensor Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Precision Biosensor's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(12708.233 + 4954.473) / 52039.024
=0.34

Precision Biosensor's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(12708.233 + 4954.473) / 52039.024
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Precision Biosensor  (XKRX:335810) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Precision Biosensor Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Precision Biosensor's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Precision Biosensor Business Description

Traded in Other Exchanges
N/A
Address
306 Techno 2-ro Yuseong-gu, Daejeon, KOR, 34036
Precision Biosensor Inc is an In Vitro Diagnostic (IVD) company that provides accurate clinical diagnosis solutions based on various disease biomarker detection technology. Its offering includes diagnostic reagent cartridges and analyzers which are the core of IVD's The company is engaged in manufacturing and development of next-generation platform technology of Europium-based Time-Resolved Fluorescence.

Precision Biosensor Headlines

No Headlines